Author

Sharon O'Byrne 1

1 Genentech Inc.,South San Francisco, CA,United S

ETROLIZUMAB TREATMENT INCREASES BLOOD LEVELS OF CD3, TREG AND TH17 CELLS MEASURED THROUGH EPIGENETIC ACTIVATION OF THE CD3, FOXP3 AND IL-17 LOCI

Franklin Fuh, Eva Raschke, Akiko Chai, Caroline Looney, Thomas Oliver Kleen, Severine Vermeire, Sharon O'Byrne, Teresa Ramirez Montagut

INCREASED EXPRESSION OF T-CELL-ASSOCIATED GENES IN BASELINE BIOPSIES FROM TNF ANTAGONIST NAIVE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO UNDERGO REMISSION IN RESPONSE TO ETROLIZUMAB IN A PHASE II TRIAL

Gaik Tew, Jason Hackney, Deena Gibbons, Christopher Andrew Lamb, Diana Luca, Jackson Egen, Severine Vermeire, John Charles Mansfield, Brian G. Feagan, Julian Panés, Daniel C. Baumgart, Stefan Schreiber, Iris Dotan, William Sandborn, John A. Kirby, Peter Irving, Gert De Hertogh, Gert Van Assche, Paul Rutgeerts, Sharon O'B

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS

Marna Williams, Mary E. Keir, Caroline Looney, Franklin Fuh, Wei Tew, Kathleen Howell, Sha Klabunde, Clarissa Johnson, Xiaohui Wei, Meina Tang, Diana Luca, Azucena Salas, Severine Vermeire, Clementine Perrier, Julian Panés, Daniel C. Baumgart, John Charles Mansfield, Maren Paulsen, Philip Rosenstiel, Stefan Schreiber, I

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Caroline Looney, Franklin Fuh, Meina Tang, Xiaohui Wei, Mary E. Keir, Gaik Tew, Jeffrey Eastham-Anderson, Lauri Diehl, Azucena Salas, Gert De Hertogh, Steven Francom, Houston Gilbert, Diana Luca, Jackson Egan, Severine Vermeire, John Charles Mansfield, Christopher Andrew Lamb, Brian G. Feagan, Julian Panés, Daniel C. Bau

SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN ADULT ULCERATIVE COLITIS AND CROHN?S DISEASE PATIENTS

Sandra M Bovens, Angela Solaman, Rebecca Curtis, Sharon O'Byrne, Javaria Mona Khalid, Dirk Demuth

Item 1 - 5 / 5
1